interpret
sar
associ
epithelialcel
prolifer
increas
macrophag
lung
presenc
haemophagocytosi
support
content
cytokin
dysregul
may
account
least
partli
sever
clinic
diseas
case
definit
sar
acknowledg
rang
lung
patholog
associ
diseas
background
sever
acut
respiratori
syndrom
sar
novel
infecti
diseas
global
impact
viru
famili
coronavirida
identifi
caus
pathogenesi
still
unclear
method
postmortem
tissu
sampl
six
patient
die
sar
februari
march
open
lung
biopsi
one
patient
studi
histolog
virolog
one
full
autopsi
done
evid
infect
sarsassoci
coronaviru
sarscov
human
metapneumoviru
sought
reversetranscriptas
pcr
serolog
patholog
sampl
examin
light
electron
microscopi
immunohistochemistri
find
six
patient
serolog
evid
recent
infect
sarscov
diffus
alveolar
damag
common
univers
morpholog
chang
identifi
bronchial
epitheli
denud
loss
cilia
squamou
metaplasia
secondari
bacteri
pneumonia
present
one
case
giantcel
infiltr
seen
four
patient
pronounc
increas
macrophag
alveoli
interstitium
lung
haemophagocytosi
present
two
patient
alveolar
pneumocyt
also
show
cytomegali
granular
amphophil
cytoplasm
patient
full
autopsi
done
atrophi
white
pulp
spleen
electron
microscopi
reveal
viral
particl
cytoplasm
epitheli
cell
correspond
coronaviru
sinc
nov
outbreak
sever
acut
respiratori
syndrom
sar
affect
countri
five
contin
report
case
death
time
write
local
transmiss
occur
least
six
countri
first
case
sar
hong
kong
special
administr
region
recognis
februari
may
case
death
region
clinic
diseas
characteris
fever
dyspnoea
lymphopenia
rapidli
progress
chang
radiographi
upperrespiratorytract
symptom
promin
diarrhoea
report
patient
respons
convent
antibiot
use
treat
atyp
pneumonia
sarsassoci
coronaviru
sarscov
consist
associ
diseas
although
viru
seem
necessari
develop
sar
localis
site
lung
patholog
poutanen
colleagu
found
human
metapneumoviru
hmpv
second
pathogen
patient
sar
postul
hmpv
potenti
progress
sever
coronaviru
infect
use
steroid
togeth
ribavirin
report
confer
clinic
benefit
although
randomis
clinic
trial
support
clinic
efficaci
avail
aid
understand
pathogenesi
diseas
relat
current
therapi
report
patholog
virolog
find
six
patient
sar
die
patient
met
modifi
case
definit
sar
underw
lung
biopsi
postmortem
examin
march
four
major
hospit
kowloon
hospit
cluster
elig
inclus
case
definit
fever
temperatur
higher
cough
short
breath
new
pulmonari
infiltr
chest
radiograph
either
histori
exposur
patient
sar
lack
respons
empir
antimicrobi
coverag
typic
atyp
pneumonia
betalactam
macrolid
fluoroquinolon
tetracyclin
owe
potenti
infecti
natur
disord
full
autopsi
done
one
case
case
postmortem
examin
limit
lung
includ
patient
pair
serum
sampl
submit
virolog
studi
cours
ill
patient
needlebiopsi
sampl
organ
avail
exclud
period
studi
six
patient
patholog
virolog
investig
one
also
underw
lung
biopsi
earlier
cours
ill
case
autopsi
materi
fix
neutral
buffer
formalin
later
process
electron
microscopi
separ
piec
fresh
tissu
sent
virolog
studi
suffici
quantiti
avail
store
immunofluoresc
studi
patient
patient
woman
good
health
ill
admit
march
histori
fever
cough
gener
muscl
pain
day
oxygen
satur
admiss
oxygen
chest
radiograph
show
patchi
hazi
patient
soon
develop
respiratori
failur
necessit
mechan
ventil
ribavirin
antibiot
treatment
start
ratio
partial
arteri
pressur
oxygen
pao
fraction
inspir
oxygen
fio
kpa
day
death
die
march
day
assist
ventil
patient
woman
previous
well
indirect
contact
person
develop
fever
return
guangzhou
china
subsequ
develop
fever
short
breath
diarrhoea
lymphopenia
admiss
chest
radiograph
show
infiltr
left
upper
zone
treatment
ribavirin
steroid
start
march
develop
respiratori
failur
next
day
intub
repeat
cardiac
arrest
die
march
patient
man
develop
influenzalik
symptom
left
pleurit
chest
pain
feb
chest
radiograph
taken
day
later
show
hazi
left
lower
zone
subject
improv
selfmed
levofloxacin
penicillin
visit
hong
kong
feb
tourist
condit
deterior
admit
directli
intensivecar
unit
intub
feb
investig
show
diffus
bilater
groundglass
chang
chest
radiograph
sever
oxygen
desatur
despit
empir
antimicrobi
coverag
typic
atyp
hospitalacquir
pneumonia
condit
continu
deterior
empir
treat
oseltamivir
foscarnet
intraven
immunoglobulin
later
stage
ribavirin
steroid
ventil
day
peak
airway
pressur
cm
water
tidal
volum
ml
pao
fio
kpa
die
march
acut
respiratori
distress
syndrom
multiorgan
failur
patient
man
histori
hypertens
develop
influenzalik
symptom
day
admiss
feb
chest
radiograph
chang
diffus
bilater
pneumonia
respiratori
failur
respond
doxycyclin
amantadin
cefotaxim
open
lung
biopsi
done
march
routin
microbiolog
virolog
investig
neg
empir
treat
oseltamivir
steroid
ribavirin
nonoligur
renal
failur
develop
later
complic
nosocomi
pneumonia
due
pseudomona
aeruginosa
die
march
ventil
day
peak
airway
pressur
cm
water
tidal
volum
ml
pao
fio
kpa
patient
businessman
histori
hepat
b
liver
cirrhosi
portal
hypertens
develop
influenzalik
symptom
hong
kong
still
travel
oversea
feb
investig
destin
show
lymphopenia
thrombocytopenia
peripher
blood
examin
bilater
pulmonari
infiltr
chest
radiograph
went
respiratori
failur
march
march
transfer
back
hong
kong
ventil
ventil
pressur
cm
water
time
posit
endexpiratori
pressur
cm
water
tidal
volum
gener
kept
ml
pao
fio
renal
function
deterior
progress
march
march
time
death
urea
concentr
mmoll
creatinin
total
bilirubin
vari
despit
intens
support
antimicrobi
coverag
piperacillintazobactam
azithromycin
oseltamivir
die
march
patient
man
good
health
previous
march
admit
hospit
increas
short
breath
fever
cough
routin
microbiolog
investig
includ
cultur
blood
sputum
bacteri
pathogen
serolog
done
complementfix
test
respiratori
virus
chlamydia
mycoplasma
pneumonia
total
rna
dna
extract
nasopharyng
aspir
viral
rna
minikit
qiamp
dna
minikit
qiagen
hilden
germani
reversetranscriptas
rt
pcr
done
influenza
adenoviru
hmpv
newli
recognis
coronaviru
subsequ
report
associ
sar
rtpcr
protocol
describ
previous
biopsi
sampl
postmortem
lung
tissu
homogenis
tissu
grinder
supernat
inocul
onto
cell
cultur
viral
rna
extract
tissu
rneasi
minikit
qiagen
accord
manufactur
tissu
protocol
instruct
rtpcr
novel
coronaviru
hmpv
carri
describ
serial
dilut
serum
acut
convalesc
patient
test
parallel
antibodi
coronaviru
hmpv
indirect
immunofluoresc
test
cell
infect
respect
viru
role
fund
sourc
sponsor
studi
role
studi
design
data
collect
analysi
interpret
write
report
antemortem
investig
routin
bacteri
viral
respiratori
pathogen
prove
unremark
howev
six
patient
fourfold
greater
rise
antibodi
titr
clinic
present
two
patient
patient
report
previous
one
patient
patient
open
lung
biopsi
done
death
materi
divid
four
piec
one
sent
viral
studi
one
frozen
one
fix
formalin
one
fix
glutaraldehyd
latter
process
transmiss
electron
microscopi
immunohistochemistri
paraffinembed
block
lung
tissu
section
dewax
standard
procedur
monoclon
antibodi
dako
carpintaria
ca
usa
keratin
tcell
macrophag
marker
appli
section
stain
done
ventana
nex
autom
immunohistochem
stainer
frozen
postmortem
lung
tissu
one
patient
patient
avail
studi
cryostat
section
stain
directli
conjug
monoclon
antibodi
influenza
virus
b
adenoviru
parainfluenza
viru
dako
usa
examin
nikon
eclips
fluoresc
microscop
biopsi
sampl
patient
materi
pleural
tissu
small
amount
lung
parenchyma
architectur
preserv
mild
increas
interstiti
lymphocyt
cytomegali
present
pneumocyt
characteris
nuclear
enlarg
promin
nucleolu
amphophil
granular
cytoplasm
figur
typic
viral
inclus
identifi
mild
moder
increas
alveolar
macrophag
earli
hyalinemembran
format
gross
find
postmortem
lung
tissu
similar
among
patient
tabl
lung
remov
en
bloc
weigh
g
oedemat
greyish
brown
consolid
cut
surfac
consolid
irregular
patchi
foci
pale
tissu
measur
sever
millimetr
diamet
diffus
involv
seen
one
case
patient
mucopurul
materi
seen
tracheobronchi
tree
case
diseas
durat
less
day
histolog
involv
lung
vari
mix
inflammatori
infiltr
oedema
hyalinemembran
format
seen
figur
tabl
intraalveolar
oedema
granular
vacuol
desquam
pneumocyt
promin
consist
featur
figur
case
show
scatter
singl
enlarg
cell
associ
larg
nuclei
promin
nucleoli
similar
find
open
lung
biopsi
sampl
clear
chromatin
also
seen
giantcel
format
seen
within
alveolar
lumen
four
case
cell
contain
amphophil
basophil
cytoplasm
granul
within
enlarg
pneumocyt
one
patient
patient
show
fibrin
thrombi
within
pulmonari
vessel
anoth
patient
show
intim
swell
pulmonari
vessel
three
four
case
giant
cell
cytoplasm
therefor
hypothesis
cytoplasm
amphophilia
may
due
viral
assembl
within
golgi
apparatusa
featur
seen
electron
microscopi
open
lung
biopsi
sampl
patient
histolog
chang
uncompl
viral
pneumonia
rare
describ
report
tend
deriv
postmortem
examin
patient
succumb
pneumonia
thu
may
repres
major
pneumonia
patient
surviv
true
sar
patient
admit
hospit
suitabl
medic
condit
warrant
biopsi
howev
sever
featur
fatal
coronavir
pneumonia
identifi
coronaviru
infect
earli
stage
seem
stimul
epitheli
cell
result
cellular
prolifer
squamou
metaplasia
lung
pneumocyt
hyperplasia
hypertrophi
also
identifi
porcin
reproduct
respiratori
syndrom
viru
arteriviru
tent
classifi
coronavirida
well
porcin
respiratori
coronaviru
previous
known
transmiss
gastroenter
viru
respiratori
variant
infect
mild
pneumocyt
prolifer
associ
squamou
metaplasia
sar
macrophag
prolifer
promin
consolid
area
lung
distribut
also
seen
porcin
respiratori
coronaviru
contrast
typic
diffus
alveolar
damag
neutrophil
fibroblast
main
cellular
agent
macrophag
lesser
role
patient
fatal
sar
macrophag
promin
leucocyt
alveoli
even
earli
stage
diseas
find
haemophagocytosi
lung
whitepulp
atrophi
spleen
identifi
sar
reminisc
report
fatal
influenza
subtyp
diseas
haemophagocytosi
attribut
cytokin
dysregul
lymphopenia
anoth
featur
common
sarscov
influenza
pneumonia
virus
cross
human
be
anim
bird
experiment
studi
macrophag
infect
vitro
suggest
compar
convent
human
influenza
virus
subtyp
influenza
virus
isol
hyperinduc
proinflammatori
cytokin
human
coronaviru
replic
human
macrophag
vitro
taken
togeth
similar
clinic
patholog
chang
sarscov
pneumonia
pneumonia
suggest
proinflammatori
cytokin
releas
stimul
macrophag
alveoli
promin
role
pathogenesi
sar
result
cytokin
dysregul
idea
implic
manag
coronavir
pneumonia
intervent
steroid
might
modul
cytokin
respons
prevent
fatal
outcom
propos
nonvir
acut
respiratori
distress
syndrom
although
find
pcr
evid
secondari
viral
infect
hmpv
pig
infect
isol
porcin
respiratori
coronaviru
respiratori
lesion
sever
enough
predispos
pig
secondari
bacteri
mycoplasm
infect
lead
combin
viral
infect
alreadi
mention
histolog
featur
porcin
reproduct
respiratori
syndrom
viru
infect
similar
sarscov
infect
possibl
sarscov
infect
human
be
may
open
door
secondari
infect
previous
report
patient
receiv
ribavirin
therapi
still
pcr
electronmicroscop
evid
sarscov
lung
find
support
clinic
evid
search
articl
lancet
vol
may
wwwthelancetcom
posit
macrophag
marker
figur
one
case
posit
epitheli
marker
patient
frozen
tissu
avail
stain
identifi
adenoviru
parainfluenza
viru
influenza
virus
b
frozensect
immunofluores
one
patient
time
onset
symptom
death
day
show
squamou
metaplasia
bronchi
loss
cilia
figur
addit
within
parenchyma
also
within
interstitium
increas
number
mononuclear
cell
focal
haemophagocytosi
figur
risk
infect
postmortem
examin
limit
chest
patient
full
autopsi
done
pronounc
whitepulp
atrophi
spleen
seen
case
electron
microscopi
show
dilat
golgi
apparatu
cytoplasm
pneumocyt
within
organel
nm
viral
particl
small
extern
spike
correspond
coronaviru
identifi
figur
particl
similar
morpholog
report
previous
six
patient
describ
serolog
evid
recent
infect
sarscov
five
evid
viral
rna
detect
sampl
taken
death
previou
studi
healthi
control
patient
unrel
diseas
evid
sarscov
antibodi
rna
serum
respiratori
tract
respect
patient
diseas
durat
less
day
hyalinemembran
format
pneumocyt
prolifer
oedema
diffus
alveolar
damag
seen
case
longer
durat
diffus
alveolar
damag
typic
goe
exud
phase
follow
prolif
phase
although
other
describ
threestag
process
inflammatori
exud
phase
prolif
phase
final
fibrot
phase
viral
infect
result
diffus
alveolar
damag
typic
fall
two
categori
influenza
virus
b
adenoviru
caus
case
viral
pneumonia
immunocompet
adult
immunocompromis
host
suscept
pneumonia
caus
cytomegaloviru
herpesvirus
measl
viru
adenoviru
addit
diffus
alveolar
damag
morpholog
featur
giant
cell
pneumocyt
hyperplasia
appear
promin
viral
infect
seen
patient
multinucl
giant
cell
within
alveoli
previous
report
patient
sar
deriv
remain
unclear
document
three
patient
giant
cell
macrophag
origin
one
patient
epitheli
origin
giant
cell
present
antemortem
lung
biopsi
sampl
present
patient
diseas
progress
longer
day
admiss
anim
coronavirus
induc
syncytium
format
cell
cultur
sarscov
also
induc
focal
syncitium
format
vero
cell
bronchial
epitheli
denud
loss
cilia
squamou
metaplasia
earli
featur
anoth
notabl
featur
presenc
larg
pneumocyt
show
enlarg
nucleu
granular
amphophil
cytoplasm
chang
also
seen
open
lung
biopsi
sampl
patient
coronaviru
assembl
take
place
golgi
apparatu
cytoplasm
section
coronavirusinfect
cultur
process
characteris
swell
increas
granular
promis
antivir
agent
high
prioriti
treatment
diseas
recent
case
definit
sar
autopsi
done
state
autopsi
featur
show
chang
respiratori
distress
syndrom
without
identifi
caus
includ
wherea
without
respiratori
distress
syndrom
exclud
previou
report
featur
late
case
diffus
alveolar
damag
pronounc
seri
serolog
confirm
case
show
rang
morpholog
chang
sar
diseas
less
day
durat
chang
respiratori
distress
syndrom
may
focal
dissimilar
previous
publish
case
pathologist
undertak
autopsi
awar
vari
rang
morpholog
chang
